{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:38:52Z","timestamp":1790257132806,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG002132"],"award-info":[{"award-number":["AG002132"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG031220"],"award-info":[{"award-number":["AG031220"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00401-019-01959-4","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T21:27:42Z","timestamp":1548710862000},"page":"437-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines"],"prefix":"10.1007","volume":"137","author":[{"given":"Amanda L.","family":"Woerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeen A.","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefkos T.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Gentleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Mordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-5498","authenticated-orcid":false,"given":"Stanley B.","family":"Prusiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"1959_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","volume":"3","author":"ME Bernis","year":"2015","unstructured":"Bernis ME, Babila JT, Breid S, W\u00fcsten KA, W\u00fcllner U, Tamg\u00fcney G (2015) Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol Commun 3:75","journal-title":"Acta Neuropathol Commun"},{"key":"1959_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0092-8674(86)90875-5","volume":"46","author":"GA Carlson","year":"1986","unstructured":"Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S et al (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503\u2013511","journal-title":"Cell"},{"key":"1959_CR3","doi-asserted-by":"publisher","first-page":"10434","DOI":"10.1523\/JNEUROSCI.2831-08.2008","volume":"28","author":"L Dimou","year":"2008","unstructured":"Dimou L, Simon C, Kirchhoff F, Takebayashi H, Gotz M (2008) Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 28:10434\u201310442","journal-title":"J Neurosci"},{"key":"1959_CR4","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut P-O, Rockenstein E, Masliah E, Levine MS et al (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human \u03b1-synuclein. J Neurosci 24:9434\u20139440","journal-title":"J Neurosci"},{"key":"1959_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"1959_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J et al (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429","journal-title":"Mol Cell Neurosci"},{"key":"1959_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","volume":"24","author":"T Gomez-Isla","year":"2003","unstructured":"Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S et al (2003) Motor dysfunction and gliosis with preserved dopaminergic markers in human \u03b1-synuclein A30P transgenic mice. Neurobiol Aging 24:245\u2013258","journal-title":"Neurobiol Aging"},{"key":"1959_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","volume":"32","author":"JG Graham","year":"1969","unstructured":"Graham JG, Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32:28\u201334","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1959_CR9","doi-asserted-by":"publisher","first-page":"e36402","DOI":"10.7554\/eLife.36402","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R et al (2018) Cryo-EM structure of alpha-synuclein fibrils. eLife 7:e36402","journal-title":"eLife"},{"key":"1959_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.22648","volume":"62","author":"W Huang","year":"2014","unstructured":"Huang W, Zhao N, Bai X, Karram K, Trotter J, Goebbels S et al (2014) Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous differentiation potential of NG2 glia during development. Glia 62:896\u2013913","journal-title":"Glia"},{"key":"1959_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.brainres.2008.10.011","volume":"1250","author":"M Ikeda","year":"2009","unstructured":"Ikeda M, Kawarabayashi T, Harigaya Y, Sasaki A, Yamada S, Matsubara E et al (2009) Motor impairment and aberrant production of neurochemicals in human \u03b1-synuclein A30P\u2009+\u2009A53T transgenic mice with \u03b1-synuclein pathology. Brain Res 1250:232\u2013241","journal-title":"Brain Res"},{"key":"1959_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119:657\u2013667","journal-title":"Acta Neuropathol"},{"key":"1959_CR13","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","volume":"20","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A et al (2000) Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant \u03b1-synuclein in human and transgenic mouse brain. J Neurosci 20:6365\u20136373","journal-title":"J Neurosci"},{"key":"1959_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","volume":"3","author":"PJ Kahle","year":"2002","unstructured":"Kahle PJ, Neumann M, Ozmen L, M\u00fcller V, Jacobsen H, Spooren W et al (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3:583\u2013588","journal-title":"EMBO Rep"},{"key":"1959_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.stemcr.2017.12.001","volume":"10","author":"S Kaji","year":"2018","unstructured":"Kaji S, Maki T, Kinoshita H, Uemura N, Ayaki T, Kawamoto Y et al (2018) Pathological endogenous \u03b1-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Rep 10:356\u2013365","journal-title":"Stem Cell Rep"},{"key":"1959_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.neuron.2010.09.009","volume":"68","author":"SH Kang","year":"2010","unstructured":"Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE (2010) NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668\u2013681","journal-title":"Neuron"},{"key":"1959_CR17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM et al (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19:1633\u20131650","journal-title":"Hum Mol Genet"},{"key":"1959_CR18","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS et al (2002) Human \u03b1-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 \u2192 Thr mutation causes neurodegenerative disease with \u03b1-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99:8968\u20138973","journal-title":"Proc Natl Acad Sci USA"},{"key":"1959_CR19","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G et al (2018) Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun 9:3609","journal-title":"Nat Commun"},{"key":"1959_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z et al (2018) Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy. Cell Res 28:897\u2013903","journal-title":"Cell Res"},{"key":"1959_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2009.10.036","volume":"1307","author":"P Liu","year":"2010","unstructured":"Liu P, Wang X, Gao N, Zhu H, Dai X, Xu Y et al (2010) G protein-coupled receptor kinase 5, overexpressed in the \u03b1-synuclein up-regulation model of Parkinson\u2019s disease, regulates bcl-2 expression. Brain Res 1307:134\u2013141","journal-title":"Brain Res"},{"key":"1959_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-015-0008-9","volume":"10","author":"M Mandler","year":"2015","unstructured":"Mandler M, Valera E, Rockenstein E, Mante M, Weninger H, Patrick C et al (2015) Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol Neurodegener 10:10","journal-title":"Mol Neurodegener"},{"key":"1959_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A et al (2000) Dopaminergic loss and inclusion body formation in a-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"1959_CR24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","volume":"35","author":"VEL May","year":"2014","unstructured":"May VEL, Ettle B, Poehler A-M, Nuber S, Ubhi K, Rockenstein E et al (2014) \u03b1-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy. Neurobiol Aging 35:2357\u20132368","journal-title":"Neurobiol Aging"},{"key":"1959_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2990.2004.00564.x","volume":"30","author":"M Nishie","year":"2004","unstructured":"Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K (2004) A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 30:546\u2013554","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1959_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fnins.2014.00133","volume":"8","author":"A Nishiyama","year":"2014","unstructured":"Nishiyama A, Suzuki R, Zhu X (2014) NG2 cells (polydendrocytes) in brain physiology and repair. Front Neurosci 8:133","journal-title":"Front Neurosci"},{"key":"1959_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","volume":"100","author":"S Nuber","year":"2018","unstructured":"Nuber S, Rajsombath M, Minakaki G, Winkler J, M\u00fcller CP, Ericsson M et al (2018) Abrogating native \u03b1-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease. Neuron 100:75\u201390","journal-title":"Neuron"},{"key":"1959_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy\u2013Drager syndrome). J Neurol Sci 94:79\u2013100","journal-title":"J Neurol Sci"},{"key":"1959_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0022-510X(92)90286-T","volume":"107","author":"MI Papp","year":"1992","unstructured":"Papp MI, Lantos PL (1992) Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107:172\u2013182","journal-title":"J Neurol Sci"},{"key":"1959_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557:558\u2013563","journal-title":"Nature"},{"key":"1959_CR31","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112:E5308\u2013E5317","journal-title":"Proc Natl Acad Sci USA"},{"key":"1959_CR32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.2220","volume":"11","author":"LE Rivers","year":"2008","unstructured":"Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A et al (2008) PDGFRA\/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11:1392\u20131401","journal-title":"Nat Neurosci"},{"key":"1959_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jnr.10231","volume":"68","author":"E Rockenstein","year":"2002","unstructured":"Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I et al (2002) Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68:568\u2013578","journal-title":"J Neurosci Res"},{"key":"1959_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/2654","volume":"4","author":"J Safar","year":"1998","unstructured":"Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M et al (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157\u20131165","journal-title":"Nat Med"},{"key":"1959_CR35","doi-asserted-by":"publisher","first-page":"49874","DOI":"10.1074\/jbc.M309127200","volume":"278","author":"R Sharon","year":"2003","unstructured":"Sharon R, Bar-Joseph I, Mirick GE, Serhan CN, Selkoe DJ (2003) Altered fatty acid composition of dopaminergic neurons expressing \u03b1-synuclein and human brains with \u03b1-synucleinopathies. J Biol Chem 278:49874\u201349881","journal-title":"J Biol Chem"},{"key":"1959_CR36","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"CW Shults","year":"2005","unstructured":"Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G et al (2005) Neurological and neurodegenerative alterations in a transgenic mouse model expressing human \u03b1-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 25:10689\u201310699","journal-title":"J Neurosci"},{"key":"1959_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1750-3639.1998.tb00162.x","volume":"8","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Bird TD, Ghetti B (1998) Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 8:387\u2013402","journal-title":"Brain Pathol"},{"key":"1959_CR38","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","volume":"20","author":"H van der Putten","year":"2000","unstructured":"van der Putten H, Wiederhold K-H, Probst A, Barbieri S, Mistl C, Danner S et al (2000) Neuropathology in mice expressing human \u03b1-synuclein. J Neurosci 20:6021\u20136029","journal-title":"J Neurosci"},{"key":"1959_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) \u03b1-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182","journal-title":"Neurosci Lett"},{"key":"1959_CR40","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM et al (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110:19555\u201319560","journal-title":"Proc Natl Acad Sci USA"},{"key":"1959_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1073\/pnas.1719369115","volume":"115","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K et al (2018) Familial Parkinson\u2019s point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci USA 115:409\u2013414","journal-title":"Proc Natl Acad Sci USA"},{"key":"1959_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-017-1762-2","volume":"135","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A et al (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49\u201363","journal-title":"Acta Neuropathol"},{"key":"1959_CR43","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman AL, St\u00f6hr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC et al (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci USA 112:E4949\u2013E4958","journal-title":"Proc Natl Acad Sci USA"},{"key":"1959_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K et al (2005) Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45:847\u2013859","journal-title":"Neuron"},{"key":"1959_CR45","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.neuron.2013.01.006","volume":"77","author":"KM Young","year":"2013","unstructured":"Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D et al (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77:873\u2013885","journal-title":"Neuron"},{"key":"1959_CR46","doi-asserted-by":"publisher","first-page":"9863","DOI":"10.1074\/jbc.M710232200","volume":"283","author":"W Zhou","year":"2008","unstructured":"Zhou W, Milder JB, Freed CR (2008) Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease. J Biol Chem 283:9863\u20139870","journal-title":"J Biol Chem"},{"key":"1959_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1242\/dev.004895","volume":"135","author":"X Zhu","year":"2008","unstructured":"Zhu X, Bergles DE, Nishiyama A (2008) NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135:145\u2013157","journal-title":"Development"},{"key":"1959_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1242\/dev.047951","volume":"138","author":"X Zhu","year":"2011","unstructured":"Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A (2011) Age-dependent fate and lineage restriction of single NG2 cells. Development 138:745\u2013753","journal-title":"Development"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-01959-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01959-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01959-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:54:24Z","timestamp":1589633664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-01959-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-01959-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"12 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Institute for Neurodegenerative Diseases has a research collaboration with Daiichi Sankyo (Tokyo, Japan). S.B.P. is the chair of the Scientific Advisory Board of Alzheon, Inc., and a member of the Scientific Advisory Board of ViewPoint Therapeutics, neither of which has contributed financial or any other support to these studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animals were maintained in an AAALAC-accredited facility in compliance with the <i>Guide for the Care and Use of Laboratory Animals<\/i>. All procedures used in this study were approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}